Introduction
Cells in a tissue environment are exposed to various signals that lead to either division or cell death. The balance between these processes is essential to maintain a constant cell number. Progression through the various phases of the cell cycle is dependent on cyclin-dependent kinases (cdks) (Morgan, 1995) . The activity of the cdks is controlled by their association with cyclins and cdk inhibitors, by their state of phosphorylation, by ubiquitin-mediated proteolysis and by their sub cellular localization. Cyclin levels in the cell¯uctuate as the cell progress through the cell cycle. G1 and G2 speci®c cyclins have been characterized (Pines, 1991) . Recently nuclear transport factors have been identi®ed ferrying CDK-cyclins in and out of nucleus and this movement has been linked to cell cycle control mechanisms (Yang and Kornbluth, 1999) .
Progression through the G2 phase into mitosis requires the activation of maturation-promoting factor (MPF), a protein kinase complex composed of a catalytic subunit, p34 cdc2 , and its regulatory subunit, cyclin B1 (reviewed in Maity et al., 1994) . During interphase the binding of cyclin B to p34 cdc2 results in the phosphorylation of p34 cdc2 on threonine 161, which is essential for its catalytic activity. The p34 cdc2 /cyclin B is held inactive because cyclin binding also results in the phosphorylation of p34 cdc2 on Thr-14 and Tyr-15 by Wee1/Mik1 and Myt1 (reviewed in Morgan, 1995) . Recently a novel Cdk1-inhibitory kinase Wee1B was identi®ed that can phosphorylate cyclin B-associated Cdk1 on tyrosine-15 (Nakanishi et al., 2000) . Cdc25 B and C are responsible for dephosphorylating both Thr-14 and Tyr-15. The accumulation of cyclin B disrupts the balance between Cdc25 and Wee1/Mik1 and Myt1 activities and the inhibitory phosphorylations on p34 cdc2 are removed leading to the activation of MPF. Cyclin F levels also increase in G2. Nuclear localization signal regions of cyclin F regulate cyclin B1 localization to the nucleus (Kong et al., 2000) . Polo-like kinase 1 (PLK-1) has also been implicated in this way (Toyoshima-Morimoto et al., 2001) . Other studies have suggested the involvement of additional mechanism(s) responsible for the regulation of the interphase to mitosis transition (Ghosh et al., 1998) .
During progression through and at the completion of mitosis, cyclin A and B are destroyed by proteolysis. The absence of cyclin B is required for further cell cycle progression. Cyclin A and B mRNA are decreased in abundance due to increased instability controlled by the action of HuR (Wang et al., 2000) . This early point in G1 is poorly characterized. During later progression through G1, the amount of D-type cyclins, increases, and, in a mitogen-regulated manner, these proteins associate with, and activate, CDK4 or CDK6 (Matsushime et al., 1994) . Cyclin E mRNA and protein also accumulate and cyclin E act as a cofactor for cdk2. Prior to the identi®cation of some of the molecular events characterizing the cell cycle, a point of no return in G1 called the restriction point had been determined. This now appears to correspond to the time at which synthesis of cyclin D and E are triggered.
The ®rst gap phase (G1) in the mammalian cell cycle plays a pivotal role in determining whether or not cells are to initiate DNA replication. Progression through G1 phase and transition into S phase are positively and negatively regulated by a series of factors, collectively termed G1 regulators (Kato, 1999) . Among them, Dtype G1 cyclins and a Cdk inhibitor, p27Kip1, function as the target of growth factors to integrate extracellular signals into cell cycle regulators. The products of at least three dierent gene families, Ink4, Cip/Kip and the pRb pocket-protein family, suppress S phase entry (Vidal and Ko, 2000) . Ink4 proteins act by antagonizing the formation and activation of cyclin D-CDK4 complexes; of which the ultimate downstream target as related to S phase entry appears to be pRb. Cip/Kip inhibitors impinge upon that pathway by inhibiting CDK2 kinases that participate in the inactivation of pRb and, like cyclin E, may also have roles independent of pRb.
Microarrays have been used to compare patterns of gene expression in which thousands of genes can be examined in a single hybridization (Schena et al., 1995 (Schena et al., , 1996 DeRisi et al., 1997) . The total number of expressed human genes was estimated to be 100 000, with 11 000 genes expressed in any particular cell type (Alberts et al., 1994) . Although recent completion of the human genome sequence has reduced the total number of genes to a third of its original estimation (Claverie, 2001) , this number does not include alternate starts and splicing. The level of expression of these genes varies, depending on a number of factors including the cell cycle phase. Recently genome-wide surveys for cell cycle regulated genes were reported in yeast (Cho et al., 1998; Spellman et al., 1998) . Similar studies are needed to identify cell cycle genes in mammalian cells and progress is being made to this end (Cho et al., 2001) . Eorts to identify new cell cycle genes using the draft human genome sequence failed (Murray and Marks, 2001) . Other investigations based on computer-assisted modeling of the structural features of the 5' regulatory regions of genes were successful in identifying cell cyclerelated genes (Kel et al., 2001) . In the present study we monitored the global gene expression pro®le of G2 phase and early G1 human cells using high-density microarrays to begin to understand the G2 to G1 transition. Our large scale gene expression pro®ling has permitted us to catalog the genes that could be involved in human cell cycle progression.
Results
HeLa cells were synchronized in G1 or G2 cell cycle phase as described in Materials and methods. The synchronized G2 cells were in late G2 and before early G1 using the double thymidine block method. Flow cytometry was employed to con®rm their G1/S or G2/ M status (Figure 1 ). Total RNA was isolated from these cells to prepare target for probe array hybridization. Aymetrix HGU95A GeneChip was used for target hybridization and the data was analysed with GeneChip microarray suite version 4 (Aymetrix). Independently isolated G1 and G2 samples from three dierent experiments were analysed with GeneChip. Using the microarray software, absolute analysis for all six samples was performed. The resultant absolute data ®les were used to run comparison analysis between G1 and G2. Comparison was done in both directions i.e., ®rst with G1 absolute analysis as baseline and ®nally G2 absolute analysis data ®le as baseline. Fold changes between the baseline and experimental samples were calculated. The fold change values derived by using the noise were excluded from the analysis. The data was ®ltered to isolate genes showing at least threefold change. The fold change values from all the three experiments were aligned in the excel spreadsheet and only genes seen in all experiments were selected. Table 1 shows a list of transcripts that were elevated in G2 phase as compared to G1 and Table 2 contains the genes found to be upregulated in G1 as compared to G2 genes. A total of 154 genes were found to be upregulated in G2 (Table 1) . Among these there were 15 genes with no known function. On the other hand the expression of only 19 genes was elevated in G1 phase (Table 2) and six of these genes were with unknown function. The number of genes upregulated in G2 in two experiments out of three was 221 and similarly there were 73 genes upregulated in G1 (data not shown). We then used the cluster program to determine the hierarchical clustering. This method identi®es similarity in pattern of gene expression. The resulting expression map was visualized with Tree View program and the data is shown in Figure 2 . This process results in a phylogenetic tree, the branch length of which re¯ects the degree of similarity between the samples. The genechip microarray hybridization data was further corroborated with Northern analysis. The RNA samples from G1 and G2 cells that were used to prepare target for Aymetrix probe arrays were gel electrophoresed and after transfer to nylon membrane, probed with a panel of cDNA probes. Figure 3 shows the result of representative Northerns. In all cases Northern data con®rmed pattern of alteration in gene expression obtained by microarray hybridization.
Discussion
Transition through the cell cycle involves alterations in the activities and expression of a number of genes. Recent studies in yeast with microarrays (Cho et al., 1998; Spellman et al., 1998) have revealed a comprehensive set of genes that were found to¯uctuate as the cell proceeds through the cell cycle. Our knowledge of genome wide cell cycle speci®c gene expression in mammalian cells however is very limited. In the present study we monitored the global gene expression in the transition from the G1 to the G2 phases of human HeLa cells by employing Aymetrix GeneChip covering more than 12 000 genes. Microarray data yielded expression patterns of a number of genes in G1 and G2 phases. We set very strict criteria to select G1 and G2 speci®c genes from the microarray data set requiring that all signals must be higher than background noise, and that at least a threefold change be seen in all three experiments. These strict criteria to select genes may have resulted in the exclusion of genes from the results or false negatives. Of the 154 genes found to be upregulated in G2 some were known to be upregulated in G2 such as CDC2, CDC2 delta T, CDC25Hs, CDC42 interacting protein 4 (CIP4), cyclins G1, A and F, and cyclin selective ubiquitin carrier protein. The observation of increased expression of the expected genes in the G2 phase gives increased con®dence in our GeneChip data. The absence of cyclin B was notable however, increased cyclin B was seen in two out of three experiments. The diculty in picking up this expected gene might be because on the GeneChip U95A used in these studies, only probes corresponding to the 3' end of cyclin B are present. The DNAdependent protein kinase (DNA-PK) was expressed in G2. Earlier studies have shown the G2 speci®c expression of DNA-PK and have predicted the involvement of DNA-PK for exit from a DNA damage-induced G2 checkpoint arrest (Lee et al., 1997) . Another interesting gene that was expressed in G2 is gelsolin. Recent studies have shown that gelsolin enhances G2 checkpoint function of cells through lipid metabolism (Sakai et al., 1999) . Less expected genes including polymorphic epithelial mucin, 14-3-3 epsilon, Cdc42-interacting protein 4, DNA topoisomerase II, laminin and unknown such as KIAA0250 and the putative serine/threonine protein kinase, IMAGE-2063822 emerged. Also unexpected was the elevation in transcription level of various oncogenes. Among these were N-ras, B-myb, raf, ras related protein Rap1b, myc-associated zinc-®nger protein and LUCA1/HYAL1. The observation of elevation of ras, raf, and MAP kinase pathway genes was perhaps the most unexpected. Recent studies have shown that Ras activity during G2 phase induces cyclin D1 expression and this expression continues through the next G1 phase even in the absence of Ras activity, and drives cells into S phase (Hitomi and Stacey, 2001) . Fifteen novel genes were also identi®ed. Genes upregulated in early G1 prior to the restriction point have not previously been documented. Cyclins D1 and E were not seen, con®rming the early G1 status of these cells. The other genes observed to markedly change in level in early G1 are now candidates to test for function in cell cycle progression in early G1. Although gene expression changes in late G1 at the restriction point have been well described, little is known about gene expression in early G1. Maximum expression of chromobox homolog 6, PAI-1 mRNA-binding protein and ESTs AC004940 and AL049974 was observed in G1 (Table 2) . Six novel genes were also found.
Further examination of cell cycle regulated transcripts will include evaluation of common promoter elements (Werner, 2001) . The availability of the complete human genome sequence begins to provide this opportunity. A comparative promoter analysis of co-regulated genes will generate models describing the higher order levels of transcription factor binding site organization within these promoter regions. Recent studies in yeast have determined cell cycle speci®c regulators of transcription factors. Analogous factors are not yet fully known for the mammalian cells and current studies are aimed at identifying such factors (Kel et al., 2001 ).
Materials and methods

Cell culture and flow cytometry
HeLa cells were cultured at 378C in DMEM medium (Life Technologies, Gaithersburg, MD, USA) with 5% fetal calf serum, penicillin, and streptomycin. All the chemicals for cell synchronization were obtained from Sigma Inc. Subcon¯uent cultures were trypsinized and plated at 10 6 cells per 140-mm culture dish. A thymidine/aphidicolin double block (Maity et al., 1995; Heintz, 1993) was used to synchronize the cells at Figure 3 Veri®cation of G1 and G2 speci®c genes by Northern analysis. The RNA was prepared from HeLa cells collected in G1 and G2 cell cycle phase and probed with putative G1 and G2 speci®c probes. The G1 probes were as follows. a: IMAGE-2054467, b: IMAGE-47383, c: IMAGE-855873, d: IMAGE-1403679 . The G2 probes were, e: gelsolin, f: mitochondrial citrate transport protein, g: KIAA0353 h: laminin beta 2. rpl is ribosomal protein L which was used as a control probe for RNA loading the G1/S interface. Brie¯y, 2 mM thymidine was added to the exponentially growing cells. Twelve hours later the thymidine was washed out and fresh DMEM containing 2.5610 75 M thymidine and deoxycytidine was added. After 14 h, 2 mg/ml of aphidicolin was added and 12 h later the cells were released from the aphidicolin block. Eight, nine, ten and eleven hours after release from aphidicolin block, cells were harvested for¯ow cytometry and RNA isolation. Ten hour time point gave the highest percentage of G2/M cells and were used to prepare target for GeneChip.
Nocodazole blocking was also used to synchronize cells. Cells were treated with 40 ng/ml nocodazole (Sigma) for 16 h. The¯oating cells were then harvested in culture medium with gentle rocking. The cells were washed in cold medium without nocodazole and plated in warmed medium. Samples were taken for¯ow cytometric analysis of G2/M population. G1 enriched cells were harvested after 5 h of incubation for¯ow analysis and for RNA isolation.
Flow cytometric analysis was performed to measure the DNA content and cell cycle distribution in the cells. All reagents for¯ow cytometry were purchased from Sigma. The cells harvested for¯ow cytometry were immediately frozen in liquid nitrogen in 1 ml of 40 mM citrate buer and 5% dimethyl sulfoxide (DMSO). The samples were immediately stored at 7708C. At the time of analysis cells were thawed and stained with propidium iodide as described by Vindelov and Christensen (1990) . Cells were resuspended in 16PBS and then sequentially treated with 0.003% trypsin solution, followed by 0.05% trypsin inhibitor, 0.01% RNase A solution, and then stained with 0.0416% propidium iodide and 5 mM spermine tetrachloride solution. Each treatment was performed for 10 min with continuous shaking at room temperature. Cell cycle analysis was performed within 2 h of staining on a Becton Dickinson FACScan¯ow cytometer. Ten thousand events were collected for each sample and the data was analysed by using the MODFIT TM version 2.0 cell cycle analysis software (Becton Dickinson).
GENECHIP olidonucleotide microarrays target preparation
GeneChips were purchased from Aymetrix, Santa Clara, CA, USA. Target preparation and microarray processing was done according to the manufacturer's recommendation. Total RNA was prepared from cells by using Trizol TM reagent (Life Technologies, Gaithersburg, MD, USA) followed by puri®cation with a Qiagen RNeasy kit. Thirty mg of total RNA was used to prepare double-stranded cDNA with Superscript II reverse transcriptase (Life Technologies, Gaithersburg, MD, USA) and a T7-(dT)24 primer containing a T7 RNA polymerase promoter site (Genset Corp., La Jolla, CA, USA). Biotinylated cRNA was synthesized from 5 mg of cDNA with RNA transcript labeling kit (Enzo Diagnostics). A total of 25 ± 50 mg of the cRNA product in buer [40 mM Tris/acetate (pH 8.1)/100 mM potassium acetate/30 mM magnesium acetate] was fragmented at 948C for 35 min to approximately 50 ± 200 nucleotides.
Targets for hybridization were prepared by combining 15 mg of fragmented cRNA with sonicated herring sperm DNA (0.1 mg/ml) plus four control bacterial and phage cRNA (1.5 pM BioB, 5 pM BioC, 25 pM BioD, and 100 pM Cre) samples to serve as internal controls for hybridization eciency in a buer containing 1.0 M NaCl, 10 mM Tris-HCl (pH 7.6), and 0.005% Triton X-100. The target was hybridized to an Aymetrix HGU95A chip containing probes for 12 000 human genes for 16 h at 458C with constant rotation at 60 r.p.m. Chips were washed at 508C with 66SSPE (0.9 M NaCl, 60 mM NaH 2 PO 4 , 6 mM EDTA, 0.005% Triton X-100, pH 7.6), then at 408C with 0.56SSPE. The stain included streptavidin-phycoerythrin (10 mg/ml; Molecular Probes) and biotinylated goat anti-streptavidin (3 mg/ml; Vector Laboratories). Chips were washed and stained by using the EukGE-WS2 protocol on an Aymetrix uidics station. Fluorescence intensities were captured with an argon-ion laser confocal scanner (Hewlett-Packard) with a 488-nm emission and detection at 570 nm.
Analysis of GeneChip data
Scanned output ®les were visually inspected for hybridization artifacts and then analysed with GeneChip microarray suite 4 software (Aymetrix). Fluorescence intensity was measured for each chip and normalized to the average¯uorescence intensity for the entire chip. The expression value (average dierence) for each gene was determined by calculating the average of dierences of intensity (perfect match intensity minus mismatch intensity) between its probe pairs. The expression analysis ®les created by GeneChip microarray suite 4 software were imported in Microsoft Access database and linked to Internet genome databases with EASI TM software (Aymetrix). Fold changes were determined by dividing the mean intensity of each experiment by the mean intensity of the comparison value. Additional softwares used for data mining include SPOTFIRE PRO 3.0 (Spot®re, Goteborg, Sweden) and for cluster analysis were GENE CLUSTER and TREEVIEW programs .
Northern analysis
The cDNA clones to be used as probes on Northerns were purchased from Research Genetics (Huntsville, AL, USA) and American type tissue culture collection (Manassas, VA, USA). The plasmid DNA was puri®ed with a commercially available kit (Qiagen Inc.). The cDNA inserts were isolated from agorase gel with QIAquick TM gel extraction kit (Qiagen Inc.) following digestion of the plasmid DNA with appropriate restriction enzymes and electrophoresis. Alternatively the cDNA inserts were directly ampli®ed by PCR from bacterial cultures. Twenty-®ve mg of total RNA was size fractionated by electrophoresis through a 1% agarose gel containing formaldehyde. The RNA was pressure blotted (Stratagene Inc.) to Hybond-N nylon membrane (Amersham Pharmacia Biotech). Using a random priming kit (Life Technologies Inc.) for DNA labeling and [ 32 P]dATP (New England Nuclear), the cDNA probes were generated to a speci®c activity of 1.5 ± 6.0610 9 d.p.m. mg DNA. The hybridization was carried out in glass bottles at 428C overnight in a rotisserie hybridization oven (Hybaid). The blots were washed with 26SSC/0.1% SDS at room temperature for 5 min, with 16SSC/0.1% SDS at 688C for 30 min, and two washes with 0.16SSC/0.1% SDS at 688C for 30 min. Hybridization pattern was detected by autoradiography and PhosphorImager TM (Molecular Dynamics). For PhosphorImager TM analysis the membranes were exposed to PhosphorImager TM screens, and the signal intensities were analysed by Image Quant TM software (Molecular Dynamics).
